Newsroom

The Emerging Role of Circulating Tumor DNA in Gastrointestinal Stromal Tumor

In this webinar, “The Emerging Role of Circulating Tumor DNA in Gastrointestinal Stromal Tumor”, Dr. Bialick discussed recent data looking at treatment outcomes based off KIT resistant mutations identified by circulating tumor DNA in patients with GIST.

By |2022-10-20T10:20:37-04:00October 20th, 2022|Events, GIST Education, Webcast|

Jess Ly Runs for the Cause – A Half Marathon for the LRG & GIST Awareness

During the pandemic and in September 2020, Jess Ly was diagnosed with GIST cancer. The Life Raft Group (LRG) community, her GIST friends, and the cancer community welcomed her with open arms. Now she's running a half marathon to raise awareness and funds for #GISTresearch!

By |2022-10-14T09:39:40-04:00October 7th, 2022|Advocacy, Events, Fundraising, News|

Collaborative Effort Produces Position Paper on Need for Advanced Biomarker Testing

The Life Raft Group was recently part of team of authors on a collaborative position paper entitled 'Undetected KIT and PDGFRA mutations: an under-recognised cause of gastrointestinal stromal tumours (GISTs) incorrectly classified as wild-type published' in Pathology: The Journal of the Royal College of Pathologists of Australia.

By |2022-08-15T16:05:39-04:00August 15th, 2022|Mutational Testing, News, Research|
Go to Top